MoonPharmacy.com (MP) is an online research-based natural pharmaceutical company.
Our mission is to end disease.
MoonPharmacy.com has recently developed an new CB2 Specific Cannabinoid similar to CBD called MP-111. It is non-toxic, 100% non-psychoactive, pharmaceutical-grade, 100% natural, legal in all 50 states/world, fda approved, and has absolutely no side effects. CB2 Specific Cannabinoids/agonists are NIH patented and approved as treatments/prevention for all Cancers, HIV, Autism, Diabetes, Heart Disease, CFS/ME, MD, MS, ADHD, PTSD, Alzheimer's Disease, and most human diseases. Because of CB2 specific celluar activation, BCP has tremendous potential to treat and prevent most human diseases.
Our Cancer Research is solely focused on the R/D of the US National Institutes of Health (NIH), which is the World's largest Medical Research Organization. The NIH is an agency of the United States Department of Health and Human Services and is the primary agency of the United States government responsible for biomedical and health-related research. It is also the parent organization of the US National Cancer Institute.
Our Cancer Research has led to the most important medical discovery of human history....The US Government/NIH has discovered the human ENDOCANNABINOID SYSTEM (ECS) in 1992. This incredible groundbreaking medical discovery is completely unknown to the general public and to 99% of all Cancer research organizations.
Simply put, the ECS controls ALL Human Functions...including: the IMMUNE SYSTEM, the CENTRAL NERVOUS SYSTEM, PNS, DIGESTIVE/CARDIOVASCULAR SYSTEM, Pain, Mood, Memory, Appetite, Sleep, Liver, Kidney, Skin, Bone, Natural Killer Cells (Cancer), ETC.
This ECS refers to a group of neuromodulatory lipids (endocannabinoids and exogenous cannabinoids), enzymes (that synthesize and degrade the lipids), and their Cannabinoid cell receptors (CB) that are activated by the lipids. Cannabinoids
are a class of diverse chemical compounds that activate cannabinoid receptors on cells membranes. These cannabinoid cell receptor proteins are activated by three major ligands/lipids: endocannabinoids (produced naturally in the body by humans and animals), the phyto/plant cannabinoids (found naturally in most plants), and synthetic cannabinoids. Cannabinoid cell receptors
are a class of cell membrane receptors under the G protein-coupled receptor superfamily. There are currently two known subtypes of CB cell receptors, termed CB1and CB2. The CB1 cell receptor is expressed mainly in the brain (central nervous system or "CNS"), but also in the lungs, liver and kidneys. The CB2 cell receptor is expressed mainly in the Immune System and in hematopoietic cells. Mounting evidence suggests that there are novel cannabinoid cell receptors that is, non-CB1
, which are expressed in endothelial cells and in the CNS. CB3 is the orphan GPR55 cell receptor. There is mounting evidence that the GPR18 cell receptor is actually the CB4 cell receptor and the GPR119 cell receptor is actually the CB5 cell receptor.
Every human and most living species have an Endocannabinoid System. (ECS) This ECS human cellular protective system is 600 million years old and controls most human (cellular) functions. (Immune/Central Nervous/Digestive/Cardiovascular Systems, appetite, mood, memory, pain, sleep, etc) All 100 trillion cells in the human body have Cannabinoid Cell Receptors.
Recently discovered, the nucleus is not the "brain" of the human cell; instead, the cell membrane is actually the brain of the human cell. AGAIN, THE CELL MEMBRANE IS THE "BRAIN" OF THE HUMAN CELL. This is a groundbreaking medical discovery that changes everything we know about genetics. It literally turns upside down the notion that diseases are passed on genetically. Diseases are NOT hereditary. The nucleus is actually the reproductive (cell division) part of the human cell. (Bruce Lipton: NIH Cell Biologist) This is critical because Cannabinoid Cell Receptors are located on cell membranes. Cannabinoids and the Endocannabinoid System tell the human cell "brain" what to do, including cell death in Cancer by Natural Killer (NK) Cell activation. (CB2 Cell Receptors are incredibally located on NK Cells) That means that the brain of the human cell is receiving (DNA) information from external sources. This external source is Cannabinoids. Cannabinoids tell the human cell what to do. We also produce naturally two (and counting: 3 more endocannabinoids have been discovered) Endocannabinoids (endogenous) called Anandamide and 2AG. Anandamide's discovery ends the debate of Cannabinoid's medical significance. HUMANS PRODUCE CANNABINOIDS (ANANDAMIDE AND 2AG) NATURALLY. This is another groundbreaking medical discovery.
US Patent 6,630,507 was funded and researched by our United States National Institutes of Health. It is the largest Medical Research Organization on the planet. This patent was then awarded and assigned to the United States of America as represented by the Department of Health and Human Services on October 7, 2003. The patent states that "the invention (CANNABINOIDS) is treatment and prevention (vaccine) for most human oxidative diseases: including all Cancers, Arthritis, HIV, Diabetes, Heart Disease, Autism, Alzhiemer's Disease, MS, MD, Colitis, CFS/ME, and Hepatitis." The United States of America patented vaccines for all human disease on October 7, 2003. Humans have naturally produced endogenous Cannabinoids (Endocannabinoids) for over 600 million years and it was incredibally only discovered in 1992. This is the most significant medical discovery in human history. It will forever change medical research and cellular-targeted therapeutics.
The FDA has already approved two prescription Pharmaceutical Cannabinoids in 1985...Dronabinol (Marinol) and Nabilone. (Cesamet) The NIH/DHHS has also US patented over 1000 synthetic Cannabinoid compounds for NIH research. MoonPharmacy.com has developed generic versions of these NIH/FDA synthetic Cannabinoid compounds at significantly lower costs.
The first Cannabinoid was discovered in 1942 by NIH Researcher Roger Adams. This medical miracle was patented on December 8, 1942: US Patent #2,304,669.
There are over 1000 US patents belonging to the US Government/NIH on Cannabinoids.
Las Vegas, NV